Is	O
Modern	O
Medical	B:C1444483
Management	I:C1444483
Changing	O
Ultimate	O
Patient	O
Outcomes	O
in	O
Inflammatory	O
Bowel	I:C0021390
Disease	I:C0021390
?.	O

Is	O
Modern	O
Medical	O
Management	I:C1444483
Changing	O
Ultimate	O
Patient	O
Outcomes	O
in	O
Inflammatory	B:C0021390
Bowel	I:C0021390
Disease	I:C0021390
?.	O

The	O
impact	O
of	O
modern	O
medical	B:C1444483
management	I:C1444483
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
on	O
surgical	O
necessity	I:C0587668
and	O
outcomes	O
remains	O
unclear	O
.	O

The	O
impact	O
of	O
modern	O
medical	O
management	I:C1444483
of	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
on	O
surgical	O
necessity	I:C0587668
and	O
outcomes	O
remains	O
unclear	O
.	O

The	O
impact	O
of	O
modern	O
medical	O
management	I:C1444483
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
)	O
on	O
surgical	O
necessity	I:C0587668
and	O
outcomes	O
remains	O
unclear	O
.	O

The	O
impact	O
of	O
modern	O
medical	O
management	I:C1444483
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
on	O
surgical	B:C0587668
necessity	I:C0587668
and	O
outcomes	O
remains	O
unclear	O
.	O

We	O
hypothesized	O
that	O
surgery	B:C0543467
rates	O
have	O
decreased	O
while	O
outcomes	O
have	O
worsened	O
due	O
to	O
operating	O
on	O
"	O
sicker	O
"	O
patients	O
since	O
the	O
introduction	O
of	O
biologic	O
medications	I:C1531518
.	O

We	O
hypothesized	O
that	O
surgery	O
rates	O
have	O
decreased	O
while	O
outcomes	O
have	O
worsened	B:C1457868
due	O
to	O
operating	O
on	O
"	O
sicker	O
"	O
patients	O
since	O
the	O
introduction	O
of	O
biologic	O
medications	I:C1531518
.	O

We	O
hypothesized	O
that	O
surgery	O
rates	O
have	O
decreased	O
while	O
outcomes	O
have	O
worsened	O
due	O
to	O
operating	B:C0543467
on	O
"	O
sicker	O
"	O
patients	O
since	O
the	O
introduction	O
of	O
biologic	O
medications	I:C1531518
.	O

We	O
hypothesized	O
that	O
surgery	O
rates	O
have	O
decreased	O
while	O
outcomes	O
have	O
worsened	O
due	O
to	O
operating	O
on	O
"	O
sicker	B:C0221423
"	O
patients	O
since	O
the	O
introduction	O
of	O
biologic	O
medications	I:C1531518
.	O

We	O
hypothesized	O
that	O
surgery	O
rates	O
have	O
decreased	O
while	O
outcomes	O
have	O
worsened	O
due	O
to	O
operating	O
on	O
"	O
sicker	O
"	O
patients	O
since	O
the	O
introduction	O
of	O
biologic	B:C1531518
medications	I:C1531518
.	O

The	O
Nationwide	O
Inpatient	O
Sample	O
and	O
ICD	B:C1137112
-9	I:C1137112
-	I:C1137112
CM	I:C1137112
codes	I:C1137112
were	O
used	O
to	O
identify	O
inpatient	O
admissions	O
for	O
Crohn	O
's	I:C0010346
disease	I:C0010346
and	O
ulcerative	O
colitis	I:C0009324
.	O

The	O
Nationwide	O
Inpatient	O
Sample	O
and	O
ICD	O
-9	I:C1137112
-	I:C1137112
CM	I:C1137112
codes	I:C1137112
were	O
used	O
to	O
identify	O
inpatient	O
admissions	B:C0184666
for	O
Crohn	O
's	I:C0010346
disease	I:C0010346
and	O
ulcerative	O
colitis	I:C0009324
.	O

The	O
Nationwide	O
Inpatient	O
Sample	O
and	O
ICD	O
-9	I:C1137112
-	I:C1137112
CM	I:C1137112
codes	I:C1137112
were	O
used	O
to	O
identify	O
inpatient	O
admissions	O
for	O
Crohn	B:C0010346
's	I:C0010346
disease	I:C0010346
and	O
ulcerative	O
colitis	I:C0009324
.	O

The	O
Nationwide	O
Inpatient	O
Sample	O
and	O
ICD	O
-9	I:C1137112
-	I:C1137112
CM	I:C1137112
codes	I:C1137112
were	O
used	O
to	O
identify	O
inpatient	O
admissions	O
for	O
Crohn	O
's	I:C0010346
disease	I:C0010346
and	O
ulcerative	B:C0009324
colitis	I:C0009324
.	O

Trends	O
in	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
nutrition	O
,	O
surgeries	O
,	O
and	O
postoperative	O
complications	I:C0032787
were	O
determined	O
.	O

Trends	O
in	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
nutrition	B:C0392209
,	O
surgeries	O
,	O
and	O
postoperative	O
complications	I:C0032787
were	O
determined	O
.	O

Trends	O
in	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
nutrition	O
,	O
surgeries	B:C0543467
,	O
and	O
postoperative	O
complications	I:C0032787
were	O
determined	O
.	O

Trends	O
in	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
nutrition	O
,	O
surgeries	O
,	O
and	O
postoperative	B:C0032787
complications	I:C0032787
were	O
determined	O
.	O

There	O
were	O
191,743	O
admissions	B:C0184666
for	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
during	O
the	O
study	O
period	O
.	O

There	O
were	O
191,743	O
admissions	O
for	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
during	O
the	O
study	O
period	O
.	O

There	O
were	O
191,743	O
admissions	O
for	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
during	O
the	O
study	B:C2603343
period	O
.	O

Surgery	B:C0543467
rates	O
were	O
largely	O
unchanged	O
over	O
the	O
study	O
period	O
,	O
ranging	O
from	O
9	O
to	O
12	O
%	O
of	O
admissions	O
in	O
both	O
Crohn	O
's	I:C0010346
disease	I:C0010346
and	O
ulcerative	O
colitis	I:C0009324
.	O

Surgery	O
rates	O
were	O
largely	O
unchanged	B:C0442739
over	O
the	O
study	O
period	O
,	O
ranging	O
from	O
9	O
to	O
12	O
%	O
of	O
admissions	O
in	O
both	O
Crohn	O
's	I:C0010346
disease	I:C0010346
and	O
ulcerative	O
colitis	I:C0009324
.	O

Surgery	O
rates	O
were	O
largely	O
unchanged	O
over	O
the	O
study	B:C2603343
period	O
,	O
ranging	O
from	O
9	O
to	O
12	O
%	O
of	O
admissions	O
in	O
both	O
Crohn	O
's	I:C0010346
disease	I:C0010346
and	O
ulcerative	O
colitis	I:C0009324
.	O

Surgery	O
rates	O
were	O
largely	O
unchanged	O
over	O
the	O
study	O
period	O
,	O
ranging	O
from	O
9	O
to	O
12	O
%	O
of	O
admissions	B:C0184666
in	O
both	O
Crohn	O
's	I:C0010346
disease	I:C0010346
and	O
ulcerative	O
colitis	I:C0009324
.	O

Surgery	O
rates	O
were	O
largely	O
unchanged	O
over	O
the	O
study	O
period	O
,	O
ranging	O
from	O
9	O
to	O
12	O
%	O
of	O
admissions	O
in	O
both	O
Crohn	B:C0010346
's	I:C0010346
disease	I:C0010346
and	O
ulcerative	O
colitis	I:C0009324
.	O

Surgery	O
rates	O
were	O
largely	O
unchanged	O
over	O
the	O
study	O
period	O
,	O
ranging	O
from	O
9	O
to	O
12	O
%	O
of	O
admissions	O
in	O
both	O
Crohn	O
's	I:C0010346
disease	I:C0010346
and	O
ulcerative	B:C0009324
colitis	I:C0009324
.	O

The	O
rate	O
of	O
poor	B:C0162429
nutrition	I:C0162429
increased	O
by	O
67	O
%	O
in	O
ulcerative	O
colitis	I:C0009324
and	O
by	O
83	O
%	O
in	O
Crohn	O
's	I:C0010346
disease	I:C0010346
.	O

The	O
rate	O
of	O
poor	O
nutrition	I:C0162429
increased	O
by	O
67	O
%	O
in	O
ulcerative	B:C0009324
colitis	I:C0009324
and	O
by	O
83	O
%	O
in	O
Crohn	O
's	I:C0010346
disease	I:C0010346
.	O

The	O
rate	O
of	O
poor	O
nutrition	I:C0162429
increased	O
by	O
67	O
%	O
in	O
ulcerative	O
colitis	I:C0009324
and	O
by	O
83	O
%	O
in	O
Crohn	B:C0010346
's	I:C0010346
disease	I:C0010346
.	O

Rates	O
of	O
postoperative	O
anastomotic	B:C0919691
leak	I:C0919691
(	O
10.2	O
-	O
13.9	O
%	O
)	O
were	O
unchanged	O
over	O
the	O
years	O
.	O

Rates	O
of	O
postoperative	O
anastomotic	O
leak	I:C0919691
(	O
10.2	O
-	O
13.9	O
%	O
)	O
were	O
unchanged	B:C0442739
over	O
the	O
years	O
.	O

Postoperative	B:C0392618
infection	I:C0392618
rates	O
decreased	O
by	O
17	O
%	O
in	O
Crohn	O
's	I:C0010346
disease	I:C0010346
(	O
18	O
%	O
in	O
2003	O
to	O
15	O
%	O
in	O
2012	O
;	O
P	O
<	O
0.001	O
)	O
but	O
did	O
not	O
show	O
a	O
trend	O
in	O
any	O
direction	O
in	O
ulcerative	O
colitis	I:C0009324
.	O

Postoperative	O
infection	I:C0392618
rates	O
decreased	O
by	O
17	O
%	O
in	O
Crohn	B:C0010346
's	I:C0010346
disease	I:C0010346
(	O
18	O
%	O
in	O
2003	O
to	O
15	O
%	O
in	O
2012	O
;	O
P	O
<	O
0.001	O
)	O
but	O
did	O
not	O
show	O
a	O
trend	O
in	O
any	O
direction	O
in	O
ulcerative	O
colitis	I:C0009324
.	O

Postoperative	O
infection	I:C0392618
rates	O
decreased	O
by	O
17	O
%	O
in	O
Crohn	O
's	I:C0010346
disease	I:C0010346
(	O
18	O
%	O
in	O
2003	O
to	O
15	O
%	O
in	O
2012	O
;	O
P	O
<	O
0.001	O
)	O
but	O
did	O
not	O
show	O
a	O
trend	O
in	O
any	O
direction	O
in	O
ulcerative	B:C0009324
colitis	I:C0009324
.	O

Rates	O
of	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
surgery	O
have	O
remained	O
stable	O
while	O
postoperative	O
infectious	I:C0032787
complications	I:C0032787
have	O
remained	O
stable	O
or	O
decreased	O
since	O
the	O
implementation	O
of	O
biologic	O
therapies	I:C1531518
.	O

Rates	O
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
surgery	B:C0038894
have	O
remained	O
stable	O
while	O
postoperative	O
infectious	I:C0032787
complications	I:C0032787
have	O
remained	O
stable	O
or	O
decreased	O
since	O
the	O
implementation	O
of	O
biologic	O
therapies	I:C1531518
.	O

Rates	O
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
surgery	O
have	O
remained	O
stable	O
while	O
postoperative	B:C0032787
infectious	I:C0032787
complications	I:C0032787
have	O
remained	O
stable	O
or	O
decreased	O
since	O
the	O
implementation	O
of	O
biologic	O
therapies	I:C1531518
.	O

Rates	O
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
surgery	O
have	O
remained	O
stable	O
while	O
postoperative	O
infectious	I:C0032787
complications	I:C0032787
have	O
remained	O
stable	O
or	O
decreased	O
since	O
the	O
implementation	B:C0018726
of	O
biologic	O
therapies	I:C1531518
.	O

Rates	O
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
surgery	O
have	O
remained	O
stable	O
while	O
postoperative	O
infectious	I:C0032787
complications	I:C0032787
have	O
remained	O
stable	O
or	O
decreased	O
since	O
the	O
implementation	O
of	O
biologic	B:C1531518
therapies	I:C1531518
.	O

We	O
identified	O
an	O
increase	O
in	O
poor	B:C0162429
nutrition	I:C0162429
in	O
surgical	O
patients	O
.	O

